The provincial government has committed $7 million in funding to a new commercialization strategy for bioscience companies in the province. The money is aimed at aiding companies in getting their research to market.
The move came in response to
a report from the
Ontario Bioscience Industry Organization, "Industry Generated Recommendations for Sustainability and Growth of Ontario's Bioscience Industry in 2010 and Beyond." The group, which represents the private sector players in bioscience research and marketing,
welcomed the investment from Queen's Park. "By providing this immediate support the province is recognizing the challenges facing Ontario bioscience companies," says OBIO president and CEO Gail Garland. "By giving these companies a shot in the arm, it will allow them to bring innovative technologies to market -- which benefits the health of Ontarians, the wealth of the province, and the health of the whole world."
Writer: Edward Keenan
Source: Gail Garland, President & CEO, Ontario Bioscience Industry Organization
Got an Inovation & Job News tip? Email [email protected].